Gohar Arslan, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-217-6939 |
Pramod Vadlamani, MD Internal Medicine - Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 22 St Paul Drive, Wellspan Medical Oncology & Hematology, Chambersburg, PA 17201 Phone: 717-217-6020 |
Dr. John Fraley Robinson, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 25 Penncraft Ave, Suite 101, Chambersburg, PA 17201 Phone: 717-387-6015 Fax: 717-217-6939 |
Michael R Cashdollar, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 22 St Paul Dr Ste 100, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-217-6939 |
Ramanda Sue Holgersson, RN Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 22 St Paul Dr Ste 100, Chambersburg, PA 17201 Phone: 717-217-6020 |
Kevin J Lorentsen, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr Ste 100, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-217-6939 |
Dr. Susan Alice Gingrich, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 22 St Paul Dr Ste 100, Chambersburg, PA 17201 Phone: 717-217-6020 |
Bibi S Khoyratty, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-857-2521 |
News Archive
The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.
Patients with recurrent glioblastoma multiforme treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro-Oncology and accompanied by an editorial highlighting the importance of the trial.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
Latinos are not all the same when it comes to risk of heart disease, and a new study by a Columbia University researcher shows key differences among Hispanic populations that doctors should take into account in trying to stem the risk of cardiovascular disease in this large and growing subset of the U.S. population.
Health care organizations can play a key role in supporting unemployed patients find a job, suggests a new study from the Centre for Urban Health Solutions of St. Michael's Hospital.
› Verified 1 days ago